CD36 and metabolic dysfunction-associated steatotic liver disease: Interestingly, a recent lipidomic study showed that the unsaturated FAs significantly differ between NAFLD-HCC and other HCC patients with lower levels in NAFLD-HCC probably due to the increase of fatty acid transporters (CD36) that resulted in depletion of serum fatty acids [98].